Relevance of protein isoforms in proteomic studies

Current Proteomics

Volumn 4, Issue 4, 2007, Pages 235-252

  Rodríguez Piñeiro, Ana M ^a   Álvarez Chaver, Paula ^a   Martínez Zorzano, Vicenta S ^a   Rodríguez Berrocal, Francisco J ^a   De La Cadena, María Páez ^a  

^a UNIVERSITY OF VIGO   (Spain)

Author keywords

Biomarkers; Cancer; Isoform; Post translational modification; Proteomics; Two dimensional electrophoresis

Indexed keywords

EID: 37549002524     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016407783221286     Document Type: Review

References (179)

1. Adkins, J.N., Varnum, S.M., Auberry, K.J., Moore, R.J., Angell, N.H., Smith, R.D., Springer, D.L. and Pounds, J.G. (2002). Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell. Proteomics 1: 947-55.
2. Ahmed, N., Oliva, K.T., Barker, G., Hoffmann, P., Reeve, S., Smith, I.A., Quinn, M.A. and Rice, G.E. (2005). Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer. Proteomics 5: 4625-36.
3. Akgul, C., Moulding, D.A. and Edwards, S.W. (2004). Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications. Cell. Mol. Life Sci. 61: 2189-99.
4. Alaiya, A., Al-Mohanna, M. and Linder, S. (2005). Clinical Cancer Proteomics: Promises and Pitfalls. J. Proteome Res. 4: 1213-22.
5. Alfonso, P., Núñez, A., Madoz-Gurpide, J., Lombardia, L., Sánchez, L. and Casal, J.I. (2005). Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 5: 2602-11.
6. Aloni-Grinstein, R., Zan-Bar, I., Alboum I., Goldfinger, N. and Rotter, V. (1993). Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene 8: 3297-305.
7. Álvarez-Chaver, P., Rodríguez-Piñeiro, A.M., Rodríguez-Berrocal, F.J., Martínez-Zorzano, V.S. and Páez de la Cadena, M. (2007). Identification of hydrophobic proteins as biomarker candidates for colorectal cancer. Int. J. Biochem. Cell Biol. 39: 529-40.
8. An, W. (2007). Histone acetylation and methylation: combinatorial players for transcriptional regulation. Subcell. Biochem. 41: 351-69.
9. Andersen, B.N. (1984). Measurement and occurrence of sulfated gastrins. Scand. J. Clin. Lab. Invest. Suppl. 168: 5-24.
10. Andersen, C.L., Schepeler, T., Thorsen, K., Birkenkamp-Demtroder, K., Mansilla, F., Aaltonen, L.A., Laurberg, S. and Orntoft, T.F. (2007). Clusterin expression in normal mucosa and colorectal cancer. Mol. Cell. Proteomics 6: 1039-48.
11. Anderson, N.L. and Anderson, N.G. (2002). The Human Plasma Proteome. History, character, and diagnostic prospects. Mol. Cell. Proteomics 1: 845-67.
12. Apweiler, R., Hermjakob, H. and Sharon, N. (1999). On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1473: 4-8.
13. Bartel, F., Taubert, H. and Harris, L.C. (2002). Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell 2: 9-15.
14. Barten, D.M. and O'Dea, R.F. (1990). The function of protein carboxylmethyltransferase in eucaryotic cells. Life Sci. 47: 181-94.
15. Bastiani, P. and Rognoni, J.B. (1988). Monoiodotyrosine formation during thyroglobulin processing in Golgi vesicles. Cell Biochem. Funct. 6:149-53.
16. Bateman, A., Solomon, S. and Bennett, H.P. (1990). Post-translational modification of bovine pro-opiomelanocortin. Tyrosine sulfation and pyroglutamate formation, a mass spectrometric study. J. Biol. Chem. 265: 22130-6.
17. Bijlmakers, M.J. and Marsh, M. (2003). The on-off story of protein palmitoylation. Trends Cell Biol. 13: 32-42.
18. Black, D.L. (2003). Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72: 291-336.
19. Blencowe, B.J. (2006). Alternative splicing: New insights from global analyses. Cell 126: 37-47.
20. Bossis, G. and Melchior, F. (2006). SUMO: regulating the regulator. Cell Div. 1: 13-20.
21. Brett, D., Hanke, J., Lehmann, G., Haase, S., Delbrück, S., Krueger, S., Reich, J. and Bork, P. (2000). EST comparison indicates 38% of human mRNAs contain possible alternative splice forms. FEBS Lett. 474: 83-6.
22. Bristol, J.A., Furie, B.C. and Furie, B. (1993). Propeptide processing during factor IX biosynthesis. Effect of point mutations adjacent to the propeptide cleavage site. J. Biol. Chem. 268: 7577-84.
23. Broillet, M.C. (1999). S-nitrosylation of proteins. Cell Mol. Life Sci. 55: 1036-42.
24. Carlsson, S.R. (1993). Isolation and characterization of glycoproteins. In Glycobiology: A practical approach (eds. M. Fukuda and A. Kobata), Oxford University Press, Nueva York, pp 1-25.
25. Charrier, J.P., Tournel, C., Michel, S., Comby, S., Pasagot, J., Dalbon, P., Chautard, D. and Jolivet, M. (2001). Differential diagnosis of prostate cancer and benign prostate hyperplasia using two-dimensional electrophoresis. Electrophoresis 22: 1861-66.
26. Charrier, J.P., Tournel, C., Michel, S., Dalbon, P. and Jolivet, M. (1999). Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia. Electrophoresis 20: 1075-81.
27. Chen, P.L., Chen, Y.M., Bookstein, R. and Lee, W.H. (1990). Genetic mechanisms of tumor suppression by the human p53 gene. Science 250: 1576-80.
28. Chew, E.H. and Hagen, T. (2007). Substrate-mediated regulation of cullin neddylation. J. Biol. Chem. 282: 17032-40.
29. Christensson, A., Björk, T., Nilsson, O., Dahlén, U., Matikainen, M.T., Cockett, A.T., Abrahamsson, P.A. and Lilja, H. (1993). Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J. Urol. 150: 100-05.
30. Corfield, T. (1992). Mucus glycoproteins, super glycoforms: how to solve a sticky problem. Glycoconj. J. 9: 217-21.
31. Cossu, G., Manca, M., Strahler, J.R., Hanash, S.M. and Righetti, P.G. (1986). Detection of electrophoretically silent mutations by immobilized pH gradients. J. Chromatogr. 361: 223-29.
32. Courtois, S., de Fromentel, C.C. and Hainaut, P. (2004). p53 protein variants: structural and functional similarities with p63 and p73 isoforms. Oncogene 23: 631-38.
33. Cuperlovic-Culf, M., Belacel, N., Culf, A.S. and Ouellette, R.J. (2006). Data analysis of alternative splicing microarrays. Microarrays Drug Discovery Today 11: 983-90.
34. Davis, M.J., Hanson, K.A., Clark, F., Fink, J.L., Zhang, F., Kasukawa, T., Kai, C., Kawai, J., et al. (2006). Differential use of signal peptides and membrane domains is a common occurrence in the protein output of transcriptional units. PLoS Genet. 2: e46.
35. de Noo, M.E., Tollenaar, R.A.E.M., Deelder, A.M. and Bouwman, L.H. (2006). Current status and prospects of clinical proteomics studies on detection of colorectal cancer: Hopes and fears. World J. Gastroenterol. 12: 594-01.
36. Debbas, M. and White, E. (1993). Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7: 546-54.
37. Decca, M.B., Carpio, M.A., Bosc, C., Galiano, M.R., Job, D., Andrieux, A. and Hallak, M.E. (2007). Post-translational arginylation of calreticulin: a new isospecies of calreticulin component of stress granules. J. Biol. Chem. 282: 8237-45.
38. Diamandis, E.P. (1998). Prostate-specific antigen: its usefulness in clinical medicine. Trends Endocrinol. Metab. 9: 310-16.
39. Diamandis, E.P. (2006). Serum proteomic profiling by Matrix-Assisted Laser Desorption- Ionization Time-of-Flight Mass Spectrometry for cancer diagnosis: Next steps. Cancer Res. 66: 5540-1.
40. Eddé, B., Rossier, J., Le Caer, J.P., Desbruyères, E., Gros, F. and Denoulet, P. (1990). Posttranslational glutamylation of alpha-tubulin. Science 247: 83-5.
41. Eliyahu, D., Raz, A., Gruss, P., Givol, D. and Oren, M. (1984). Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature 312: 646-9.
42. Eriksson, J.E., He, T., Trejo-Skalli, A.V., Härmälä- Braskén, A.S., Hellman, J., Chou, Y.H. and Goldman, R.D. (2004). Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments. J. Cell Sci. 117: 919-32.
43. Farzan, M., Mirzabekov, T., Kolchinsky, P., Wyatt, R., Cayabyab, M., Gerard, N.P., Gerard, C., Sodroski, J., et al. (1999). Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96: 667-76.
44. Faustino, N.A. and Cooper, T.A. (2003). Pre-mRNA splicing and human disease. Genes Dev. 17: 419-37.
45. Feng, L., Lin, T., Uranishi, H., Gu, W. and Xu, Y. (2005). Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol. Cell Biol. 25: 5389-95.
46. Finlay, C.A., Hinds, P.W. and Levine, A.J. (1989). The p53 proto-oncogene can act as a suppressor of transformation. Cell 57: 1083-93.
47. Fleischhacker, M. and Schmidt, B. (2007). Circulating nucleic acids (CNAs) and cancer: a survey. Biochim. Biophys. Acta 1775: 181-232.
48. Frelin, C., Ladoux, A. and D'angelo, G. (2000). Vascular endothelial growth factors and angiogenesis. Ann. Endocrinol. 61: 70-4.
49. Friedman, D.B., Hill, S., Keller, J.W., Merchant, N.B., Levy, S.E., Coffey. R.J. and Caprioli, R.M. (2004). Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 4: 793-811.
50. Frost, B., Syed, S.K., Kim, S. and Paik, W.K. (1990). Effect of enzymatic methylation of cytocrome c on its function and synthesis. Int. J. Biochem. 22: 1069-74.
51. Fukada, Y., Takao, T., Ohguro, H., Yoshizawa, T., Akino, T. and Shimonishi, Y. (1990) Farnesylated gamma-subunit of photoreceptor G protein indispensable for GTP-binding. Nature 346: 658-60.
52. Gevaert, K., Van Damme, P., Ghesquière, B., Impens, F., Martens, L., Helsens, K. and Vandekerckhove, J. (2007). A la carte proteomics with an emphasis on gel-free techniques. Proteomics DOI 10.1002/pmic.200700114.
53. Gharbi, S., Gaffney, P., Yang, A., Zvelebil, M.J., Cramer, R., Waterfield, M.D. and Timms, J.F. (2002). Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol. Cell Proteomics 1: 91-8.
54. Gillette, M.A., Mani, D.R. and Carr, S.A. (2005). Place of pattern in proteomic biomarker discovery. J. Proteome Res. 4: 1143-54.
55. Godovac-Zimmermann, J., Kleiner, O., Brown, L.R. and Drukier, A.K. (2005) Perspectives in spcicing up proteomics with splicing. Proteomics 5: 699-709.
56. Hancock, J.F., Magee, A.I., Childs, J.E. and Marshall, C.J. (1989). All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57: 1167-77.
57. Hannisdal, E., Tveit, K.M., Theodorsen, L. and Host, H. (1994). Host markers and prognosis in recurrent rectal carcinomas treated with radiotherapy. Acta Oncol. 33: 415-21.
58. Harauz, G. and Musse, A.A. (2007). A tale of two citrullines - structural and functional aspects of myelin basic protein deimination in health and disease. Neurochem. Res. 32: 137-58.
59. Heidecker, B. and Hare, J.M. (2007). The use of transcriptomic biomarkers for personalized medicine. Heart Fail Rev. 12: 1-11.
60. Helfand, B.T., Chang, L. and Goldman, R.D. (2004). Intermediate filaments are dynamic and motile elements of cellular architecture. J. Cell Sci. 117: 133-41.
61. Herrmann, H., Hesse, M., Reichenzeller, M., Aebi, U. and Magin, T.M. (2003). Functional complexity of intermediate filament cytoskeletons: from structure to assembly to gene ablation. Int. Rev. Cytol. 223: 83-175.
62. Holben, D.H. and Smith, A.M. (1999). The diverse role of selenium within selenoproteins: a review. J. Am. Diet Assoc. 99: 836-43.
63. Holmila, R., Fouquet, C., Cadranel, J., Zalcman, G. and Soussi, T. (2003). Splice mutations in the p53 gene: case report and review of the literature. Hum Mutat. 21: 101-2.
64. Huang, H.L., Stasyk, T., Morandell, S., Dieplinger, H., Falkensammer, G., Griesmacher, A., Mogg, M., Schreiber, M., et al. (2006). Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/ MALDI-TOF/TOF and data validation by routine clinical assays Electrophoresis 27: 1641-50.
65. Huber, P.R., Schmid, H.P., Mattarelli, G., Strittmatter, B., van Steeenbrugge, G.J. and Maurer, A. (1995). Serum free prostate specific antigen: isoenzymes in benign hyperplasia and cancer of the prostate. Prostate 27: 212-9.
66. Hunzinger, C., Schrattenholz, A., Poznanovi, S., Schwall, G.P. and Stegmann, W. (2006a). Comparison of different separation technologies for proteome analyses: isoform resolution as a prerequisite for the definition of protein biomarkers on the level of posttranslational modifications. J. Chromatogr. A 1123: 170-81.
67. Hunzinger, C., Wozny, W., Schwall, G.P., Poznanovic, S., Stegmann, W., Zengerling, H., Schoepf, R., Groebe, K., et al. (2006b). Comparative profiling of the mammalian mitochondrial proteome: multiple aconitase-2 isoforms including N- formylkynurenine modifications as part of a protein biomarker signature for reactive oxidative species. J. Proteome Res. 5: 625-33.
68. Iglewski, W.J. (1994). Cellular ADP-ribosylation of elongation factor 2. Mol. Cell. Biochem. 138: 131-3.
69. Inglese, J, Glickman, J.F., Lorenz, W., Caron, M.G. and Lefkowitz, R.J. (1992). Isoprenylation of a protein kinase. Requirement of farnesylation/alpha- carboxyl methylation for full enzymatic activity of rhodopsin kinase. J. Biol. Chem. 267: 1422-5.
70. IUBMB (1992). Biochemical Nomenclature and Related Documents. 2nd edition. Portland Press, pp 93-5.
71. IUPAC-IUB Commission on Biochemical Nomenclature (CBN) (1977). Nomenclature of multiple forms of enzymes. Recommendations (1976). J. Biol. Chem. 252: 5939-41.
72. IUPAC-IUB Commission on Biochemical Nomenclature (CBN) (1978). Nomenclature of multiple forms of enzymes. Recommendations, 1976. Eur. J. Biochem. 82: 1-3.
73. Jiang, T., Zhou, X., Taghizadeh, K., Dong, M. and Dedon, P.C. (2007). N-formylation of lysine in histone proteins as a secondary modification arising from oxidative DNA damage. Proc. Natl. Acad. Sci. USA 104: 60-5.
74. Johnson, B.C. (1981). Post-translational carboxylation of preprothrombin. Mol. Cell Biochem. 38: 77-121.
75. Johnson, C.R. and Jarvis, W.D. (2004). Caspase-9 regulation: an update. Apoptosis 9: 423-7.
76. Johnson, D.A., Akamine, P., Radzio-Andzelm, E., Madhusudan, M. and Taylor, S.S. (2001). Dynamics of cAMP-dependent protein kinase. Chem. Rev. 101: 2243-70.
77. Johnson, J.M., Castle, J., Garrett-Engele, P., Kan, Z., Loerch, P.M., Armour, C.D., Santos, R., Schadt, E.E., et al. (2003). Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302: 2141-4.
78. Johnson, P., Gray, D., Mowat, M., and Benchimol, S. (1991). Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells. Mol. Cell Biol. 11: 1-11.
79. Jung, K., Hoesel, W., Reiche, J., Deger, S., Kramer, J., Loening, S.A., Lein, M. and Stephan, C. (2007). Electrophoretic subforms of free prostate-specific antigen in serum as promising diagnostic tool in prostate cancer diagnostics. Urology 69: 320-5.
80. Kim, S.Y., Marekov, L., Bubber, P., Browne, S.E., Stavrovskaya, I., Lee, J., Steinert, P.M., Blass, J.P., et al. (2005). Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain. Neurochem. Res. 30: 1245-55.
81. Kinsella, B.T. and Maltese, W.A. (1992). rab GTP-binding proteins with three different carboxyl-terminal cysteine motifs are modified in vivo by 20-carbon isoprenoides. J. Biol. Chem. 267: 3940-5
82. Komar, A.A., Kommer, A., Krasheninnikov, I.A. and Spirin, A.S. (1993). Cotranslational heme binding to nascent globin chains. FEBS Lett. 326: 261-3.
83. Krueger, K.E. and Srivastava, S. (2007). Posttranslational protein modifications. Current implications for cancer detection, prevention, and therapeutics. Mol. Cell. Proteomics 5: 1799-810.
84. Kwong, K.Y., Bloom, G.C., Yang, I., Boulware, D., Coppola, D., Haseman, J., Chen, E., McGrath, A., et al. (2005). Synchronous global assessment of gene and protein expression in colorectal cancer progression. Genomics 86: 142-58.
85. Ladd, A.N. and Cooper, T.A. (2002). Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol. 3: reviews0008.
86. Lambalot, R.H., Gehring, A.M., Flugel, R.S., Zuber, P., LaCelle, M., Marahiel, M.A., Reid, R., Khosla, C., et al. (1996). A new enzyme superfamily - the phosphopantetheinyl transferases. Chem. Biol. 3: 923-36.
87. Lapolla, A., Tubaro, M., Fedele, D., Reitano, R., Arico, N.C., Ragazzi, E., Seraglia, R., Vogliardi, S., et al. (2005). A matrix-assisted laser desorption/ionization mass spectrometry study of the non-enzymatic glycation products of human globins in diabetes. Rapid Commun. Mass Spectrom. 19: 162-8.
88. Leskov, K.S., Klokov, D.Y., Li, J., Kinsella, T.J. and Boothman, D.A. (2003). Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278: 11590-600.
89. Lewis, B.P., Green, R.E. and Brenner, S.E. (2003). Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. USA 100: 189-92.
90. Libusová, L. and Dráber, P. (2006). Multiple tubulin forms in ciliated protozoan Tetrahymena and Paramecium species. Protoplasma 227: 65-76.
91. Liou, Y.C., Ryo, A., Huang, H.K., Lu, P.J., Bronson, R., Fujimori, F., Uchida, T., Hunter, T., et al. (2002). Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. USA 99: 1335-40.
92. Lohrum, M., and Scheidtmann, K.H. (1996). Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes. Oncogene 13: 2527-39.
93. MacMillan-Crow, L.A. and Thompson, J.A. (1999). Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite. Arch. Biochem. Biophys. 366: 82-8.
94. Manning, G., Whyte, D.B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002). The protein kinase complement of the human genome. Science 298: 1912-34.
95. Melkonian, K.A., Ostermeyer, A.G., Chen, J.Z., Roth, M.G. and Brown, D.A. (1999). Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J. Biol. Chem. 274: 3910-7.
96. Mills, A.A. (2005). p53: link to the past, bridge to the future. Genes Dev. 19: 2091-9.
97. Mischak, H., Apweiler, R., Banks, R.E., Conaway, M., Coon, J., Dominiczak, A., Ehrich, J.H.H., Fliser, D., et al. (2007). Clinical proteomics: A need to define the field and begin to set adequate standards. Proteomics Clin. Appl. 1: 148-56.
98. Modrek, B. and Lee, C.J. (2002). A genomic view of alternative splicing. Nat. Genet. 30: 13-9.
99. Molero, L., García-Méndez, A., Alonso-Orgaz, S., Carrasco, C., Macaya, C. and López Farré, A.J. (2005). Proteomic approach to identify changes in protein expression modified by 17beta-oestradiol in bovine vascular smooth muscle cells. Clin. Sci. 109: 457-63.
100. Muddiman, D.C. (2006). "Lewis and Clark" proteomics. J. Proteome Res. 5: 221-2.
101. Mukhopadhyay, D. and Riezman, H. (2007). Proteasome-independent functions of ubiquitin in endocytosis and signalling. Science 315: 201-5.
102. Mukhopadhyay, T., Roth, J.A., Acosta, S.A. and Maxwell, S.A. (1998). Two-dimensional gel analysis of apoptosis-specific p53 isoforms induced by 2-methoxyestradiol in human lung cancer cells. Apoptosis 3: 421-30.
103. Muthusamy, B., Hanumanthu, G., Suresh, S., Rekha, B., Srinivas, D., Karthick, L., Vrushabendra, B.M., Sharma, S., et al. (2005). Plasma Proteome Database as a resource for proteomics research. Proteomics 5: 3531-6.
104. Nalivaeva, N.N. and Turner, A.J. (2001). Post-translational modifications of proteins: acetylcholinesterase as a model system. Proteomics 1: 735-47.
105. Nathan, D., Ingvarsdottir, K., Sterner, D.E., Bylebyl, G.R., Dokmanovic, M., Dorsey, J.A., Whelan, K.A., Krsmanovic, M., et al. (2006). Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev. 20: 966-76.
106. Nilakantan, V., Halligan, N.L., Nguyen, T.K., Hilton, G., Khanna, A.K., Roza, A.M., Johnson, C.P., Adams, M.B., et al. (2005). Posttranslational modification of manganese superoxide dismutase in acutely rejecting cardiac transplants: role of inducible nitric oxide synthase. J. Heart Lung Transplant. 24: 1591-9.
107. Nixon, R.G. and Brawer, M.K. (1997). Enhancing the specificity of prostate-specific antigen (PSA): an overview of PSA density, velocity and age-specific reference ranges. Br. J. Urol. 79: 61-7.
108. Nizard, P., Tetley, S., Le Dréan, Y., Watrin, T., Le Goff, P., Wilson, M.R. and Michel, D. (2007). Stress-induced translocation of clusterin/apoJ into the cytosol. Traffic 8: 554-65.
109. O'Connell, M.A. RNA editing: rewriting receptors. (1997). Curr. Biol. 7: 437-9.
110. O'Farrell, P.H. (1975). High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250: 4007-21.
111. Okano, T., Kondo, T., Kakisaka, T., Fujii, K., Yamada, M., Kato, H., Nishimura, T., Gemma, A., et al. (2006). Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics 6: 3938-48.
112. Oren, M., Reich, N.C. and Levine, A.J. (1983). Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny. Mol. Cell Biol. 2: 443-9.
113. Osborn, M. (1983). Intermediate filaments as histologic markers: an overview. J. Invest. Dermatol. 81: 104s-09s.
114. Pan, Q., Saltzman, A.L., Kim, Y.K., Misquitta, C., Shai, O., Maquat, L.E., Frey, B.J. and Blencowe, B.J. (2006). Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsense-mediated mRNA decay to control gene expression. Genes Dev. 20: 153-8.
115. Pavon, E.J., Munoz, P., Lario, A., Longobardo, V., Carrascal, M., Abian, J., Martin, A.B., Arias, S.A., et al. (2006). Proteomic analysis of plasma from patients with systemic lupus erythematosus: Increased presence of haptoglobin alpha2 polypeptide chains over the alpha1 isoforms. Proteomics 6: S282-92.
116. Peracaula, R., Royle, L., Tabarés, G., Mallorquí- Fernández, G., Barrabés, S., Harvey, D., Dwek, R.A., Rudd, P.M., et al. (2003a). Glycosylation of human pancreatic ribonuclease: differences between normal and tumour states. Glycobiology 13: 227-44.
117. Peracaula, R., Tabarés. G., Royle, L., Harvey, D.J., Dwek, R.A., Rudd, P.M. and de Llorens, R. (2003b). Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology 13: 457-70.
118. Pereira-Leal, J.B., Hume, A.N. and Seabra, M.C. (2001). Prenylation of Rab GTPases: molecular mechanisms and involvement in genetic disease. FEBS Lett. 498: 197-200.
119. Pérez-Sala, D. (2007). Protein isoprenylation in biology and disease: general overview and perspectives from studies with genetically engineered animals. Front. Biosci. 12: 4456-72.
120. Petricoin, E.F., Zoon, K.C., Kohn, E.C., Barrett, J.C. and Liotta, L.A. (2002). Clinical proteomics: translating benchside promise into bedside reality. Nat. Rev. Drug Discov. 1: 683-95.
121. Polley, A.C., Mulholland, F., Pin, C., Williams, E.A., Bradburn, D.M., Mills, S.J., Mathers, J.C. and Johnson, I.T. (2006). Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res. 66: 6553-62.
122. Poon, T.C.W., Mok, T.S.K., Chan, A.T.C., Chan, C.M.L., Leong, V., Tsui, S.T.H., Leung, T.W.T., Leung, T.W., et al. (2002). Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein. Clin. Chem. 48: 1021-7.
123. Rahbar, S. (2005). The discovery of glycated hemoglobin: a major event in the study of nonenzymatic chemistry in biological systems. Ann. N. Y. Acad. Sci. 1043: 9-19.
124. Ramaswamy, S. and Perou, C.M. (2003). DNA microarrays in breast cancer: the promise of personalised medicine. Lancet 361: 1576-7.
125. Rattan, S.I. (1996). Synthesis, modifications, and turnover of proteins during aging. Exp. Gerontol. 31: 33-47.
126. Ravindran, S., Radke, G.A., Guest, J.R. and Roche, T.E. (1996). Lipoyl domain-based mechanism for the integrated feedback control of the pyruvate dehydrogenase complex by enhancement of pyruvate dehydrogenase kinase activity. J. Biol. Chem. 271: 653-62.
127. Reddy, K.B., Jin, G., Karode, M.C., Harmony, J.A.K. and Howe, P.H. (1996). Transforming growth factor beta (TGFbeta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells. Biochemistry 35: 6157-63.
128. Resh, M.D. (2006). Trafficking and signaling by fatty-acylated and prenylated proteins. Nat. Chem. Biol. 2: 584-90.
129. Rifai, N., Gillette, M.A. and Carr, S.A. (2006). Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24: 971-83.
130. Rocks, O., Peyker, A., Kahms, M., Verveer, P.J., Koerner, C., Lumbierres, M., Kuhlmann, J., Waldmann, H., et al. (2005). An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307: 1746-52.
131. Rodríguez-Piñeiro, A.M., Carvajal-Rodríguez, A., Rolán-Alvarez, E., Rodríguez-Berrocal, F.J., Martínez- Fernández, M. and Páez de la Cadena, M. (2005). Application of relative warp analysis to the evaluation of two-dimensional gels in proteomics: studying isoelectric point and relative molecular mass variation. J. Proteome Res. 4: 1318-23.
132. Rodríguez-Piñeiro, A.M., Páez de la Cadena, M., López-Saco, A. and Rodríguez-Berrocal, F.J. (2006). Differential expression of serum clusterin isoforms in colorectal cancer. Mol. Cell. Proteomics 5: 1647-57.
133. nd, Kim, Y.B., Robinson, D.E. and Kelleher, N.L. (2005). Precise and parallel characterization of coding polymorphisms, alternative splicing, and modifications in human proteins by mass spectrometry. Mol. Cell Proteomics 4: 1002-8.
134. Schnell, J.D. and Hicke, L. (2003). Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J. Biol. Chem. 278: 35857-60.
135. Schröder, F.H., van der Cruijsen-Koeter, I., de Koning, H.J., Vis, A.N., Hoedemaeker, R.F., and Kranse, R. (2000). Prostate cancer detection at low prostate specific antigen. J. Urol. 163: 806-12.
136. Selkirk, J.K., He, C.Y., Patterson, R.M. and Merrick, B.A. (1996). Tumor suppressor p53 gene forms multiple isoforms: evidence for single locus origin and cytoplasmic complex formation with heat shock proteins. Electrophoresis 17: 1764-71.
137. Shoji, S. and Kubota, Y. (1989). Function of protein myristoylation in cellular regulation and viral proliferation. Yakugaku Zasshi. 109: 71-85.
138. Sinha, P., Poland, J., Schnölzer, M., Celis, J.E. and Lage, H. (2001). Characterization of the differential protein expression associated with thermoresistance in human gastric carcinoma cell lines. Electrophoresis 22: 2990-3000.
139. Solá, R.J., Rodríguez-Martínez, J.A. and Griebenow, K. (2007). Modulation of protein biophysical properties by chemical glycosylation: biochemical insights and biomedical implication. Cell Mol. Life Sci. 64: 2133-2152.
140. Stenman, U.H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K. and Alfthan, O. (1991). A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res. 51: 222-6.
141. + binding S100A6 protein in normal, preneoplastic and neoplastic colon mucosa. Eur. J. Cancer 36: 1050-9.
142. Sumi, S., Arai, K., Kitahara, S. and Yoshida, K. (1999). Serial lectin affinity chromatography demonstrates altered asparagine-linked sugar chain structures of prostate-specific antigen in human prostate carcinoma. J. Chromatogr. B Biomed. Sci. Appl. 727: 9-14.
143. Tabarés, G., Jung, K., Reiche, J., Stephan, C., Lein, M., Peracaula, R., de Llorens, R. and Hoesel, W. (2007). Free PSA forms in prostatic tissue and sera of prostate cancer patients: analysis by 2-DE and western blotting of immunopurified samples. Clin. Biochem. 40: 343-50.
144. Tabarés, G., Radcliffe, C.M., Barrabés, S., Ramírez, M., Aleixandre, R.N., Hoesel, W., Dwek, R.A., Rudd, P.M., et al. (2006). Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology 16: 132-45.
145. Takemoto, L. and Emmons, T. (1991). Age-dependent deamidation of the major intrinsic polypeptide from lens membranes. Curr. Eye Res. 10: 865-9.
146. Taylor, M.E. and Drickamer, K. (2006). Introduction to glycobiology, 2nd ed. Oxford University Press, Oxford.
147. Thazhath, R., Jerka-Dziadosz, M., Duan, J., Wloga, D., Gorovsky, M. A., Frankel, J. and Gaertig, J. (2004). Cell context-specific effects of the beta-tubulin glycylation domain on assembly and size of microtubular organelles. Mol. Biol. Cell. 15: 4136-47.
148. Thompson, P.R and Fast, W. (2006). Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock? ACS Chem. Biol. 1: 433-41.
149. Tonge, R., Shaw, J., Middleton, B., Rowlinson, R., Rayner, S., Young, J., Pognan, F., Hawkins, E., et al. (2001). Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1: 377-96.
150. Troiani, S., Uggeri, M., Moll, J., Isacchi, A., Kalisz, H.M., Rusconi, L. and Valsasina, B. (2005). Searching for biomarkers of Aurora-A kinase activity: identification of in vitro substrates through a modified KESTREL approach. J. Proteome Res. 4: 1296-303.
151. Urbani, A., Poland, J., Bernardini, S., Bellincampi, L., Biroccio, A., Schnölzer, M., Sinha, P. and Federici, G. (2005). A proteomic investigation into etoposide chemo-resistance of neuroblastoma cell lines. Proteomics 5: 796-804.
152. Varki, A. (2001). N-glycolylneuraminic acid deficiency in humans. Biochimie 83: 615-22.
153. VerBerkmoes, N.C., Bundy, J.L., Hauser, L., Asano, K.G., Razumovskaya, J., Larimer, F., Hettich, R.L. and Stephenson, J.L. (2002). Integrating "top-down" and "bottom-up" mass spectrometric approaches for proteomic analysis of Shewanella oneidensis. J. Proteome Res. 1: 239-52.
154. Verrills, N.M. (2006). Clinical proteomics: Present and future prospects. Clin. Biochem. Rev. 27: 99-116.
155. Villanueva, J., Philip, J., Entenberg, D., Chaparro, C.A., Tanwar, M.K., Holland, E.C. and Tempst, P. (2004). Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal. Chem. 76: 1560-70.
156. Vogelstein, B., and Kinzler, K.W. (1992). p53 function and dysfunction. Cell 70: 523-6.
157. Vorburger, K., Kitten, G. T. and Nigg, E. A. (1989). Modification of nuclear lamin proteins by a mevalonic acid derivative occurs in reticulocyte lysates and requires the cysteine residue of the C-terminal CXXM motif. EMBO J. 8: 4007-13.
158. Vranka, J.A., Sakai, L.Y. and Bächinger, H.P. (2004). Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J. Biol. Chem. 279: 23615-21.
159. Wallace, J.C., Jitrapakdee, S. and Chapman-Smith, A. (1998). Pyruvate carboxylase. Int. J. Biochem. Cell Biol. 30: 1-5.
160. Wallis, N.G. and Perham, R.N. (1994). Structural dependence of post-translational modification and reductive acetylation of the lipoyl domain of the pyruvate dehydrogenase multienzyme complex. J. Mol. Biol. 236: 209-16.
161. Walsh, C.T. (2006). Posttranslational modifications of proteins: Expanding nature's inventory. Roberts and Co. Publishers, Greenwood Village, Colorado.
162. Walsh, C.T., Garneau-Tsodikova, S. and Gatto, G.J. Jr. (2005). Protein posttranslational modifications: The chemistry of proteome diversifí cations. Angew. Chem. Int Ed. 44: 7342-72.
163. Wang, P., Yan, B., Guo, J.T., Hicks, C., and Xu, Y. (2005). Structural genomics analysis of alternative splicing and application to isoform structure modeling. Proc. Natl. Acad. Sci. USA 102: 18920-5.
164. Wang, W., Zhou, H., Lin, H., Roy, S., Shaler, T.A., Hill, .LR., Norton, S., Kumar, P., et al. (2003). Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal. Chem. 75: 4818-26.
165. Ward, M.A., Catto, J.W.F. and Hamdy, F.C. (2001). Prostate specific antigen: biology, biochemistry and available commercial assays. Ann. Clin. Biochem. 38: 633-51.
166. Wathes, D C. and Denning-Kendall, P.A. (1992). Control of synthesis and
167. Wei, G., Hobbs, C.A., Defeo, K., Hayes, C.S. and Gilmour, S.K. (2007). Polyamine-mediated regulation of protein acetylation in murine skin and tumors. Mol. Carcinog. 46: 611-7.
168. Willipinski-Stapelfeldt, B., Riethdorf, S., Assmann, V., Woelfle, U., Rau, T., Sauter, G., Heukeshoven, J. and Pantel, K. (2005). Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin. Cancer Res. 11: 8006-14.
169. Winter-Vann, A.M. and Casey, P.J. (2005). Post-prenylation-processing enzymes as new targets in oncogenesis. Review. Nat. Rev. Cancer 5: 405-12.
170. Xerri, L., Hassoun, J., Devilard, E., Birnbaum, D. and Birg, F. (1998). BCLX and the apoptotic machinery of lymphoma cells. Leuk. Lymphoma 28: 451-8.
171. Xing, X., Lai, M., Gartner, W., Xu, E., Huang, Q., Li, H. and Chen, G. (2006a). Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin. Proteomics 6: 2916-23.
172. Xing, X., Lai, M., Wang, Y., Xu, E. and Huang, Q. (2006b). Overexpression of glucose-regulated protein 78 in colon cancer. Clin. Chim. Acta 364: 308-15.
173. Xu, X., Yang, D., Ding, J.H., Wang, W., Chu, P.H., Dalton, N.D., Wang, H.Y., Bermingham, J.R. Jr., et al. (2005). ASF/SF2-regulated CaMKII-delta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 120: 59-72.
174. Yan, Y., Shay, J.W., Wright, W.E. and Mumby, M.C. (1997). Inhibition of protein phosphatase activity induces p53-dependent apoptosis in the absence of p53 transactivation. J. Biol. Chem. 272: 15220-6.
175. Yonish-Rouach, E., Grunwald, D.,Wilder, S., Kimchi, A., May, E., Lawrence, J.J., May, P. and Oren, M. (1993). p53-mediated cell death: relationship to cell cycle control. Mol. Cell Biol. 13: 1415-23.
176. Zhang, H., Kim, J.K., Edwards, C.A., Xu, Z., Taichman, R. and Wang, C.Y. (2005). Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 7: 909-15.
177. Zhang, L., Yang, N., Mohamed-Hadley, A., Rubin, S.C. and Coukos, G. (2002). Vector-based RNAi, a novel tool for isoform-specific knockdown of VEGF and anti-angiogenesis gene therapy of cancer. Biochem. Biophys. Res. Commun. 303: 1169-78.
178. Zhang, W.M., Finne, P., Leinonen, J., Vesalainen, S., Nordling, S., Rannikko, S. and Stenman, U.H. (1998). Characterization and immunological determination of the complex between prostate-specific antigen and alpha2-macroglobulin. Clin. Chem. 44: 2471-9.
179. Zhang, W.M., Finne, P., Leinonen, J., Vesalainen, S., Nordling, S. and Stenman, U.H. (1999). Measurement of the complex between prostate-specific antigen and alpha1-protease inhibitor in serum. Clin. Chem. 45: 814-21.